Hepatitis Monthly

Published by: Kowsar

WITHDRAWN: Efficacy and Side Effects of Sofosbuvir and Daclatasvir for Treatment of Hepatitis C in Thalassemia Major Patients with Treatment Experience of Interferon-Based Regimens

Jamshid Vafaeimanesh 1 , 2 , Fahimeh Safarnezhad Tameshkel 1 , Hossein Ajdarkosh 1 , Azita Azarkeyvani 3 , Mahmoodreza Khoonsari 1 , Amirhossein Faraji 1 , Masoudreza Sohrabi 1 , Sima Aten 1 , Hossein Keyvani 1 and Farhad Zamani 1 , *
Authors Information
1 Gastrointestinal and Liver Disease Research Center, Iran University of Medical Sciences, Tehran, IR Iran
2 Gastroenterology and Hepatology Disease Research Center, Qom University of Medical Sciences, Qom, IR Iran
3 Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Department of Thalassemia Clinic, Tehran, IR Iran
Article information
  • Hepatitis Monthly: 18 (9); e66419
  • Published Online: July 11, 2018
  • Article Type: Research Article
  • Received: January 17, 2018
  • Revised: June 5, 2018
  • Accepted: June 9, 2018
  • DOI: 10.5812/hepatmon.66419

To Cite: Vafaeimanesh J, Safarnezhad Tameshkel F, Ajdarkosh H, Azarkeyvani A, Khoonsari M, et al. WITHDRAWN: Efficacy and Side Effects of Sofosbuvir and Daclatasvir for Treatment of Hepatitis C in Thalassemia Major Patients with Treatment Experience of Interferon-Based Regimens, Hepat Mon. Online ahead of Print ; 18(9):e66419. doi: 10.5812/hepatmon.66419.

Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Withdrawal Note
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments